¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sex linked dominant inheritance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant character
    ¿ì¼ºÇüÁú
  • dominant complement
    ¿ì¼ºº¸Ã¼
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • dominant trait
    ¿ì¼º¼ÒÁú
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺-
  • incompletely dominant
    ºÒ¿ÏÀü¿ì¼º-
  • autosomal inheritance
    º¸Åë¿°»öüÀ¯Àü
  • alternative inheritance
    ±³´ëÀ¯Àü
  • amphigonous inheritance
    ¾çÄ£À¯Àü
  • blending inheritance
    È¥ÇÕÀ¯Àü, ±³ÀâÀ¯Àü
  • complex inheritance
    º¹ÇÕÀ¯Àü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sex
    ¼º
  • sex cord-stromal tumor tumor
    ¼º²ö°£ÁúÁ¾¾ç, ³­¼Ò¹öÆÀÁúÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant
    ¿ì¼º-, ¿ì¼¼-, ¿ìÀ§-, ¿ì¼º
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • dominant species
    ¿ì¼ºÁ¾
  • dominant trait
    ¿ì¼º¼ÒÁú
  • homozygous dominant
    µ¿Á¾Á¢Çտ켺
  • alternative inheritance
    ±³´ëÀ¯Àü
  • amphigonous inheritance
    ¾çÄ£À¯Àü
  • autosomal inheritance
    º¸Åë¿°»öüÀ¯Àü
  • blending inheritance
    ±³ÀâÀ¯Àü
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross inheritance
    ±³Â÷À¯Àü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • X-linked juvenile retinoschisis
    X¿°»öü°ü·Ã¿¬¼Ò±â¸Á¸·Ãþ°£ºÐ¸®
  • X-linked juvenile retinoschisis
    X ¿°»öü°ü·Ã¿¬¼Ò±â¸Á¸·Ãþ°£ºÐ¸®
  • X-linked lymphoproliferative syndrome
    ¼º¿°»öü ¿¬°ü ¸²ÇÁÁõ½Ä ÁõÈıº
  • agammaglobulinemia,x-linked, bruton type
    ¼º¿°»öü ¿¬°ü¼º, ºê·çÅæÇü(àõæøßäô÷ æáμàõ, ¡­úþ)
  • infantile X-linked agammaglobulinemia
    ¹Ý¼º ¼Ò¾Æ ¹«°¨¸¶±Û·ÎºÒ¸°Áõ
  • Mendelian inheritance
    ¸àµ¨À¯Àü
  • alternative inheritance
    ±³´ëÀ¯Àü(ÎßÓÛë¶îî).
  • amphigonous inheritance
    ¾çÄ£À¯Àü(å»öÑë¶îî).
  • holandric inheritance
    Çѳ²¼º À¯Àü(ùÚÑûàõë¶îî).
  • hologenic inheritance
    ÇÑ¿©¼ºÀ¯Àü(ùÚåüàõë¶îî).
  • homochronous inheritance
    µ¿½Ã±âÀ¯Àü (¡­ë¶îî).
  • homotropic inheritance
    ÈÄõÇüÁúÀ¯Àü.
  • inheritance
    À¯Àü
  • inheritance =heredity
    À¯Àü(ë¶îî).
  • inheritance, cytoplasmic
    ¼¼Æ÷Áú¼ºÀ¯Àü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzyme linked immunosorbent assay (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò¿¬°ü ¸é¿ªÀü±âÀü´ÞÁ¡
  • enzyme-linked immunosorbent assay
    È¿¼Ò¿¬°ü¸é¿ªÈíÂø¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay (ELISA)
    ¿¤¸®ÀÚ °Ë»ç
  • glycosyl phosphatidyl inositol-linked proteins
    Glycosyl phosphatidyl inositol-linked proteins
  • infantile X-linked agammaglobulinemia
    ¹Ý¼º ¼Ò¾Æ ¹«°¨¸¶±Û·ÎºÒ¸°Áõ
  • linked characters
    ¿¬¼â¼º ¼ºÁú(¡­àõòõ).
  • loosely linked gene expression
    ÇüÁú¹ßÇöÀÇ ¿¬°á¼ÒÈ­.
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • x linked hypophosphatemia
    X¿¬°ü(XÀÇÁ¸)ÀúÀλ꿰Ç÷Áõ
  • x-linked agammaglobulinemia of bruton
    ºê·çÅæÀÇ X¿¬°ü¹«°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
  • x-linked lymphoproliferative syndrome
    X-¿¬°ü¸²ÇÁ¼¼Æ÷Áõ½Ä¼ºÁõÈıº(¡­æáμ×úñø÷éá¬øàñòãÖàõý¦ý¦ÏØ)
  • autosomal dominant
    »ó¿°»öü ¿ì¼º
  • autosomal dominant disorder
    »ó¿°»öü¿ì¼º À¯ÀüÁúȯ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sex linkage
    ¼º¿¬°ü(àõ֤μ)
  • sex plasmid
    ¼º(àõ)Çö󽺹̵å
  • sex steroid binding plasma protein
    ¼º(àõ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê) Ç÷Àå(úìíì) ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • ATPase-linked pump
    ATPase¿¬°è(ææÍ¨) ÆßÇÁ
  • enzyme-linked immunosorbent assay
    È¿¼Ò¿¬°ü ¸é¿ªÈíÂø (ý£áÈ֤μØóæ¹ýåó·) ¾Æ½êÀÌ
  • flavin-linked dehydrogenase
    Ç÷¹À̺ó°áÇÕ(Ì¿ùê) Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • linked assay
    ¿¬°è(ææÍ¨)¾Æ¼¼ÀÌ
  • linked enzyme assay procedure
    ¿¬°èÈ¿¼Ò(ææÍ¨ý£áÈ) ¾Æ½êÀÌ ¹æ½Ä(Û°ãÒ)
  • linked gene
    ¿¬°üÀ¯ÀüÀÚ(֤μë¶îîí­)
  • linked reactions
    ¿¬°è¹ÝÀÀ(ͨͧÚãëë)
  • linked transduction
    ¿¬°üÇüÁúµµÀÔ(֤μû¡òõÓôìý)
  • linked transformation
    ¿¬°üº¯Çü(֤μܨû¡)
  • N-linked oligosaccharide
    N-¿¬°á ¿Ã¸®°í´çÁú(ÓØòõ)
  • O-linked oligosaccharide
    O-°áÇÕ°ú´çÁú(Ì¿ùêÍûÓØòõ)
  • pyridine-linked dehydrogenase
    ÇǸ®µò ¿¬°è(ææÍ¨) µðÇÏÀ̵å·ÎÀú³×À̽º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PHAVER pterygia-heart defects-autosomal recessive inheritance-vertebral defects-ear anomalies-radial defect...
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
AD   1) Alveolar Duct
  2) Autosomal Dominant
  3) Auris Dextra; Ri...
ACHOO autosomal dominant compelling helio-ophthalmic outburst [syndrome]
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ADCA Autosomal Dominant Cerebellar Ataxia
ADPKD Autosomal Dominant Polycystic Kidney Disease
ADNFLE Autosomal dominant nocturnal frontal lobe epilepsy
ADRP Autosomal dominant retinitis pigmentosa
CADASIL Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dominant
    ¿ì¼º, ¿ì¼ºÀÇ
    1. ¿ì¼¼ ¶Ç´Â Áö¹èÀû ¿µÇâÀ» ¹ßÈÖÇÏ´Â. À¯ÀüÇп¡¼­´Â ÇÑ ½ÖÀÌ »óµ¿¿°»öü ÇÑ Âʸ¸À¸·Î ¿î¹ÝµÇ¾îµµ ¹ßÇö °¡´ÉÇÑ. 2. ¿ì¼º ÇüÁú. ¿ì¼º ¼ÒÁú.
  • dominant character
    ¿ì¼º ÇüÁú, Áö¹èÀû Ư¼º
  • dominant cystoid macular dystrophy
    ¿ì¼º ³¶Æ÷ Ȳ¹Ý ÀÌ¿µ¾çÁõ
  • dominant exudative vitreoretinopathy
    ¿ì¼º »ïÃâÀ¯¸®Ã¼ ¸Á¸·º¯Áõ
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ
  • dominant receptor
    ¿ì¼º ¼ö¿ëü
  • dominant trait
    ¿ì¼º ¼ÒÁú
  • inheritance
    À¯Àü
  • mosaic inheritance
    ¸ðÀÚÀÌÅ© À¯Àü
  • multifactorial inheritance
    ´ÙÀÎÀÚ¼º À¯Àü, ´ÙÀÎÀÚ À¯Àü
  • pattern of inheritance
    À¯Àü Çü½Ä
  • pedigree pattern of autosomal dominant trait
    »ó¿°»öü¼º ¿ì¼º ÇüÁúÀÇ °¡°èµµ
  • chromosomal sex
    ¼º¿°»öüÀÇ
    µ¿ÀǾî=genoty
  • dual-sex therapy
    ÀÌÁß ¼º ¿ä¹ý
  • female sex
    ¿©¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
dominant frequency The frequency occurring most often in an electroencephalogram.
(05 Mar 2000)
dominant gene dominance of traits
dominant hemisphere That cerebral hemisphere containing the representation of speech and controlling the arm and leg used preferentially in skilled movements; usually the left hemisphere.
(05 Mar 2000)
dominant idea An idea that governs all one's actions and thoughts.
(05 Mar 2000)
dominant lethal trait Trait, expressed in the phenotype if present in the genotype, that precludes having descendants. All such cases are necessarily sporadic and must represent new mutations as the usual methods of classical genetics provide no means of demonstrating any genetic component whatsoever, except for tenuous arguments such as advanced paternal age. Molecular biology may help although the methods may be tedious; if there is an epistatic gene that may mask the trait, the logic is more tractable, though complex.
(05 Mar 2000)
dominant oncogene <genetics, molecular biology, oncology> A gene that stimulates cell proliferation and can drastically increase the risk of cancer development when present in a single copy.
(09 Oct 1997)
dominant species <biology, ecology, zoology> For each stratum, dominant species are those that, when ranked in descending rank order and cumulatively totaled, immediately exceed 50 percent of the total dominance measure, plus any additional species comprising 20 percent or more of the total dominance measure for the stratum.
(09 Oct 1997)
dominant trait An outstanding mental or physical characteristic.
See: dominance of traits.
(05 Mar 2000)
kidney, polycystic, autosomal dominant A genetic disorder with autosomal dominant inheritance characterised by multiple cysts in both kidneys and progressive deterioration of renal function. It is usually caused by a mutant gene at the pkd1 locus on the short arm of chromosome 16, though mutations elsewhere in the genome can also cause the disease. The age of onset of symptoms varies widely.
(12 Dec 1998)
adhesion structures linked tyrosine kinase <enzyme> Isolated from mouse embryonic stem cells
Registry number: EC 2.7.1.-
Synonym: hyk protein
(26 Jun 1999)
benzylviologen-linked aldehyde oxidoreductase <enzyme> A coenzyme a-independent tungsten-containing aldehyde oxidoreductase; from desulfovibrio gigas; n-terminal amino acid sequence given in first source
Registry number: EC 1.2.7.-
Synonym: bv-aldh
(26 Jun 1999)
recessive, x-linked A gene on the X chromosome that expresses itself only when there is no different gene present at that locus (spot on the chromosome). For example, duchenne muscular dystrophy (dmd) is an x-linked recessive disorder. A dmd boy has the dmd gene on his sole x chromosome (and so is said to be hemizgous for dmd). Although it is much rarer, a girl can have dmd (by several different means as, for example, if she has the dmd gene on both her x chromosomes and so is homozygous for dmd).
(12 Dec 1998)
x-linked On the X chromosome. Linked in genetics does not mean merely associated. An x-linked gene travels with the x chromosome and therefore is part of the x chromosome.
(12 Dec 1998)
X linked disease <disease, genetics> A genetic or inherited disease whose controlling gene or at least part of the relevant genome is carried on an X chromosome, for example haemophilia. most known conditions are recessive and thus since males have only one X chromosome they will express any such recessive character. Few dominants are known and the homozygous states are very rare so that female expression of such diseases is uncommon.
(18 Nov 1997)
X-linked gene A gene located on an X chromosome.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sex hygiene
    ¼ºÀ§»ý(ÇÐ)
  • sex kitten
    ¼ºÀû ¸Å·Â ÀÖ´Â ¾Æ°¡¾¾
  • sex linkage
    ¹Ý¼º À¯Àü
  • third sex
    µ¿¼º¾ÖÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á